[1] 马晓蕾. 健康之匙——白藜芦醇[J]. 中国商论, 2013(28):34-35.
MA X L. The key to your health-resveratrol[J]. China Business & Trade, 2013(28):34-35. (in Chinese)
[2] PARK E J, PEZZUTO J M. The pharmacology of resveratrol in animals and humans[J]. Biochim Biophys Acta, 2015, 1852(6):1071-1113.
[3] MOUCHIROUD L, MOLIN L, DALLIÈRE N, et al. Life span extension by resveratrol, rapamycin, and metformin:the promise of dietary restriction mimetics for an healthy aging[J]. BioFactors, 2010, 36(5):37-382.
[4] 王玉涛, 招穗珊, 关文达, 等. 白藜芦醇对常见肠道病毒抑制作用的实验研究[J]. 新中医, 2015, 47(2):222-224.
WANG Y T, ZHAO S S, GUAN W D, et al. Experimental study on the inhibitory effect of resveratrol on common enteroviruses[J]. Journal of New Chinese Medicine, 2015, 47(2):222-224. (in Chinese)
[5] 韩雪莲. 白藜芦醇及其类似物和衍生物的药理学研究进展[J]. 化学与生物工程, 2014, 31(4):15-19.
HAN X L. Pharmacological research progress of resveratrol and its analogues and derivatives[J]. Chemistry & Bioengineering, 2014, 31(4):15-19. (in Chinese)
[6] 李迎春, 江星, 符凤英, 等. 白藜芦醇联合厄贝沙坦对大鼠肺纤维化及TGF-β1、NF-κB的影响[J]. 临床和实验医学杂志, 2015, 14(2):83-86.
LI Y C, JIANG X, FU F Y, et al. Effects of resveratrol compined with irbesartan on pulmonary fibrosis and TGF-β1, NF-κB in rats[J]. Journal of Clinical and Experimental Medicine, 2015, 14(2):83-86. (in Chinese)
[7] 左惠荣. 白藜芦醇抑制缺氧复氧诱导心肌微血管内皮细胞凋亡的作用及机制研究[D]. 西安:第四军医大学, 2013.
ZUO H F. Resveratrol inhibits hypoxia/reoxygenation induced apoptosis of cardiac microvascular endothelial cells and its mechanism[D]. Xi'an:The Fourth Military Medical University, 2013. (in Chinese)
[8] 方芳. 白藜芦醇预处理对大鼠局灶性脑缺血/再灌注损伤神经元的保护作用及其机制[D]. 合肥:安徽医科大学, 2013.
FANG F. The protective role and mechanism of preconditioning with resveratrol on focal cerebral ischemia/reperfusion in rats[D]. Hefei:Anhui Medical University, 2013. (in Chinese)
[9] FUKUI M, CHOI H J, ZHU B T. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death[J]. Free Radic Biol Med, 2011, 49(5):800-813.
[10] 刘世昌. 白藜芦醇对大鼠慢性阻塞性肺病的抗氧化作用及其机制[D]. 昆明:昆明医科大学, 2013.
LIU S C. Antioxidation and signal mechanism of resveratrol in the acrolein-stimulated rats with chronic obstructive pulmonary disease[D]. Kunming:Kunming Medical University, 2013. (in Chinese)
[11] NDIAYE M, PHILIPPE C, MUKHTAR H, et al. The grape antioxidant resveratrol for skin disorders:promise, prospects, and challenges[J]. Arch Biochem Biophys, 2011, 508(2):164-170.
[12] 王超, 袁媛, 李乐, 等. 白藜芦醇对小鼠原代肝细胞脂滴形态和脂滴表面蛋白表达的影响[J]. 细胞与分子免疫学杂志, 2012, 28(9):911-914.
WANG C, YUAN Y, LI L, et al. Effects of resveratrol on the morphology of lipid droplets and the expression of lipid droplet-associated proteins in mouse primary hepatocytes[J]. Chinese Journal of Cellular and Molecular Immunology, 2012, 28(9):911-914. (in Chinese)
[13] 于飞. 白藜芦醇对小鼠脂肪代谢的影响研究[D]. 泰安:山东农业大学, 2015.
YU F. Effects of resveratrol on fat metabolism in mice[D]. Tai'an:Shandong Agricultural University, 2015. (in Chinese)
[14] CHO S J, JUMH U J, CHOI M S. Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice[J]. Br J Nutr, 2012, 108(12):2166-2175.
[15] REEVES P G, NIELSEN F H, FAHEY JR G C. AIN-93 purified diets for laboratory rodents:final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet[J]. J Nutr, 1993, 123(11):1939-1951.
[16] KU C R, CHO Y H, HONG Z Y, et al. The effects of high fat diet and resveratrol on mitochondrial activity of brown adipocytes[J]. Endocrinol Metab, 2016, 31(2):328-335.
[17] LAGOUGE M, ARGMANN C, GERHART-HINES Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α[J]. Cell, 2006, 127(6):1109-1122.
[18] 郑国华, 陈锦秀, 葛莉, 等. 白藜芦醇对不同饲料喂养小鼠血脂水平的影响[J]. 中国病毒病杂志, 2008, 10(5):385-387.
ZHENG G H, CHEN J X, GE L, et al. Impact of resveratrol on blood lipid level in mice fed with different foodstuffs[J]. Chinese Journal of Natural Medicine, 2008, 10(5):385-387. (in Chinese)
[19] TAURIAINEN E, LUOSTARINEN M, MARTONEN E, et al. Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation[J]. J Nutr Metab, 2011, 2011:525094.
[20] RIVERA L, MORÓN R, ZARZUELO A, et al. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats[J]. Biochem Pharmacol, 2009, 77(6):1053-1063.
[21] 谢则金, 王厚照, 张福军. 血清胆红素、尿酸、低密度脂蛋白与冠心病的关系[J]. 临床军医杂志, 2015, 43(2):119-120, 153.
XIE Z J, WANG H Z, ZHANG F J. Clinical study on correlation of bilirubin, uric acid and low density lipoprotein with coronary heart disease[J]. Clinical Journal of Medical Officers, 2015, 43(2):119-120, 153. (in Chinese)
[22] 汪俊军, 张春妮, 庄一义. 低密度脂蛋白亚组分不同特性在动脉粥样硬化中的作用[J]. 中国动脉硬化杂志, 2004, 12(2):227-228, 232.
WANG J J, ZHANG C N, ZHUANG Y Y. The role of low density lipoprotein subunits in atherosclerosis[J]. Chinese Journal of Arteriosclerosis, 2004, 12(2):227-228, 232. (in Chinese)
[23] 范永臻, 王振坤, 郭志刚. 高密度脂蛋白——重要而又尚未攻克的靶点[J]. 心血管病学进展, 2010, 31(1):37-40.
FAN Y Z, WANG Z K, GUO Z G. Using high-density lipoprotein with new therapeutic techniques[J]. Advances in Cardiovascular Diseases, 2010, 31(1):37-40. (in Chinese)
[24] 王玉明, 王静凤, 薛长湖. 胆固醇影响大鼠脂肪代谢的机制研究[J]. 营养学报, 2007, 29(6):530-534.
WANG Y M, WANG J F, XUE C H. Effects of dietary cholesterol on lipids metabolism in rats[J]. Acta Nutrimenta Sinica, 2007, 29(6):530-534. (in Chinese)
[25] 朱泽轶, 龙民慧, 王秦, 等. PM2.5对高血脂症大鼠心血管系统的影响[J]. 医学研究杂志, 2011, 40(11):32-34.
ZHU Z Y, LONG M H, WANG Q, et al. Effect of PM2.5 on hyperlipemia rats' ardiovascular system[J]. Journal of Medical Research, 2011, 40(11):32-34. (in Chinese)
[26] 姚丽梅, 李伟荣, 朱伟. 复方丹参滴丸对高血脂症小鼠血小板功能的影响[J]. 广州中医药大学学报, 2014, 31(3):430-433.
YAO L M, LI W R, ZHU W. Effect of Fufang Danshen dripping pills on platelets function of hyperlipidemic mice[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2014, 31(3):430-433. (in Chinese)
[27] 沈兴平, 邹森彪, 吴豪杰, 等. 肥胖患者氧化应激和脂肪细胞因子变化[J]. 细胞与分子免疫学杂志, 2008, 24(7):721-723, 726.
SHEN X P, ZOU S B, WU H J, et al. Circulating levels of oxidative stress and adipocytokines in obese subjects[J]. Chinese Journal of Cellular and Molecular Immunology, 2008, 24(7):721-723, 726. (in Chinese)
[28] CERIELLO A, MOTZ E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited[J]. Arterioscler Thromb Vasc Biol, 2004, 24(5):816-823.
[29] 邢宝恒, 曹亚磊, 董秀娟, 等. 白藜芦醇对妊娠期糖尿病大鼠降低血糖和抗氧化能力的影响[J]. 中药药理与临床, 2015, 31(1):59-63.
XING B H, CAO Y L, DONG X J, et al. The effects of resveratrol on antihyperglycemia and improving antioxidant ability in gestational diabetic rats[J]. Pharmacology and Clinics of Chinese Materia Medica, 2015, 31(1):59-63. (in Chinese)
[30] 朱立贤, 金征宇. 白藜芦醇苷对高脂血症大鼠血脂代谢的影响及其抗氧化作用[J]. 中成药, 2006, 28(2):260-261.
ZHU L X, JIN Z Y. Effect of polydatin on blood lipid metabolism and antioxidation in hyperlipidemia rats[J]. Chinese Traditional Patent Medicine, 2006, 28(2):260-261. (in Chinese)
[31] 宋蕊, 陈艳宇, 李婉秋, 等. 白藜芦醇对动脉粥样硬化兔血脂及血清中抗氧化酶水平的影响[J]. 重庆医学, 2014, 43(31):4169-4171, 4174.
SONG R, CHEN Y Y, LI W Q, et al. Resveratrol regulates serum lipid and antioxidant enzymes level in an atherosclerotic rabbit model[J]. Chongqing Medicine, 2014, 43(31):4169-4171, 4174. (in Chinese)
[32] 王蕾, 刘坚, 侯永清, 等. α-酮戊二酸对LPS慢性应激仔猪小肠黏膜形态与功能的影响[J]. 畜牧兽医学报, 2010, 41(1):46-52.
WANG L, LIU J, HOU Y Q, et al. The effects of α-ketoglutarate on intestinal mucosal morphology and function in piglets chronically challenged with lipopolysaccharide[J]. Acta Veterinaria et Zootechnica Sinica, 2010, 41(1):46-52. (in Chinese)
[33] XIAO K, SONG Z H, JIAO L F, et al. Developmental changes of TGF-β1 and Smads signaling pathway in intestinal adaption of weaned pigs[J]. PLoS One, 2013, 9(8):e104589.
[34] 鲍伟光, 郝月, 崔艳军, 等. 敌草快和硫辛酸对育肥猪肠道结构及消化功能的影响[J]. 动物营养学报, 2016, 28(10):3264-3274.
BAO W G, HAO Y, CUI Y J, et al. Effects of diquat and lipoic acid on intestinal morphology and digestive function of finishing pigs[J]. Chinese Journal of Animal Nutrition, 2016, 28(10):3264-3274. (in Chinese) |